Health Medical Pharma
- All
- News
- Videos
-
Russian Covid Vaccine Sputnik Could Be Available In India By April: 10 Points
Russian-made Coronavirus vaccine Sputnik -- peer-reviewed by the Lancet Medical Journal -- is undergoing trials in India and could be available for use soon. "I believe the vaccine should be available in India from March- April," Deepak Sapra, the chief of API and pharma services at Dr Reddy's Laboratories, which is manufacturing the vaccine, told...
-
More Investment In R&D, Health Insurance Must Be Slotted In 5% GST Tax Slab
Budget 2021: Experts believe that for the long-term, the government must increase the investment for R&D, equipment, and medical infrastructure, to develop a stronger healthcare system
-
App To Track People Buying Medicines For Cold, Fever In Andhra Pradesh
The Medical and Health Department of Andhra Pradesh on Saturday launched "Covid Pharma", a mobile application to keep a track of people purchasing medicines over-the-counter (OTC) for cough, cold and fever from medical stores across the state.
-
Travel, Hospitality To Take Time To Recover Post Lockdown: Experts
Pharma, medical and health equipment and digital companies are among those which have seen a jump in their business following the COVID-19.
-
Indian Pharma's Focus On Acquisitions To Limit Deleveraging: Fitch
New Delhi: In line with global trends in thepharmaceuticals sector, the focus of domestic drug firms on acquisitionsto consolidate their position will limit deleveraging for thetime being, rating agency Fitch has said. "The ongoing focus of the top Indian pharma companies' onselective acquisitions to limit deleveraging over the shortterm," Fitch...
-
Piramal Eyes Nutrition, Cough-Cold Brands to Boost Consumer Health Arm
Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.
-
Dr Reddy's Recalls Rivastigmine Tartrate Capsules from US
According to the US health regulator, Class II recall is a situation in which the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
-
US Panel: More Research Needed to Justify Universal Autism Screening
An influential US health panel said on Monday it needs more evidence to support universal screening for autism in young children who show no developmental problems, in a departure from recommendations issued by other medical groups.
-
Around 50 Million Suffer From Common Mental Disorders: Government
Around 50 million people suffer from common mental disorders like depression and anxiety, and more than 7,000 people committed suicide last year, government said on Friday.
-
Prices of 98 Drugs Not Fixed Due to Lack of Information
The government has not fixed the ceiling price of 98 drugs used for treating various diseases such as tuberculosis, cardiac conditions and infections due to non-availability of information.
-
Goal to End AIDS Epidemic by 2030 'Ambitious but Realistic': UN Chief
The world can end the AIDS epidemic by 2030, the United Nations said today, highlighting global success in rolling out life-saving drugs over the last 15 years.
-
MERS Cases Keep Coming From Samsung Hospital
Another doctor at a major hospital that has been the epicentre of MERS outbreak in Seoul has contracted the deadly virus, the government said Saturday.
-
Thailand Hospital Discharges Only MERS Case After Found Virus-Free
A 75-year-old Omani man who became Thailand's first case of Middle East Respiratory Syndrome (MERS) was discharged from hospital Friday after being declared free of the deadly virus, officials said.
-
Limp Corrected After 52 Years, Woman Walks Straight
Having fallen off her bed at the age of six months, a woman walked straight for the first time at the age of 52 following a total hip replacement (THR).
-
MERS Death Toll Rises to 31 in South Korea Outbreak, 1 New Case
Two more patients with Middle East Respiratory Syndrome (MERS) virus have died, South Korea's health ministry said on Friday bringing the total fatality to 31.
-
Russian Covid Vaccine Sputnik Could Be Available In India By April: 10 Points
Russian-made Coronavirus vaccine Sputnik -- peer-reviewed by the Lancet Medical Journal -- is undergoing trials in India and could be available for use soon. "I believe the vaccine should be available in India from March- April," Deepak Sapra, the chief of API and pharma services at Dr Reddy's Laboratories, which is manufacturing the vaccine, told...
-
More Investment In R&D, Health Insurance Must Be Slotted In 5% GST Tax Slab
Budget 2021: Experts believe that for the long-term, the government must increase the investment for R&D, equipment, and medical infrastructure, to develop a stronger healthcare system
-
App To Track People Buying Medicines For Cold, Fever In Andhra Pradesh
The Medical and Health Department of Andhra Pradesh on Saturday launched "Covid Pharma", a mobile application to keep a track of people purchasing medicines over-the-counter (OTC) for cough, cold and fever from medical stores across the state.
-
Travel, Hospitality To Take Time To Recover Post Lockdown: Experts
Pharma, medical and health equipment and digital companies are among those which have seen a jump in their business following the COVID-19.
-
Indian Pharma's Focus On Acquisitions To Limit Deleveraging: Fitch
New Delhi: In line with global trends in thepharmaceuticals sector, the focus of domestic drug firms on acquisitionsto consolidate their position will limit deleveraging for thetime being, rating agency Fitch has said. "The ongoing focus of the top Indian pharma companies' onselective acquisitions to limit deleveraging over the shortterm," Fitch...
-
Piramal Eyes Nutrition, Cough-Cold Brands to Boost Consumer Health Arm
Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.
-
Dr Reddy's Recalls Rivastigmine Tartrate Capsules from US
According to the US health regulator, Class II recall is a situation in which the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
-
US Panel: More Research Needed to Justify Universal Autism Screening
An influential US health panel said on Monday it needs more evidence to support universal screening for autism in young children who show no developmental problems, in a departure from recommendations issued by other medical groups.
-
Around 50 Million Suffer From Common Mental Disorders: Government
Around 50 million people suffer from common mental disorders like depression and anxiety, and more than 7,000 people committed suicide last year, government said on Friday.
-
Prices of 98 Drugs Not Fixed Due to Lack of Information
The government has not fixed the ceiling price of 98 drugs used for treating various diseases such as tuberculosis, cardiac conditions and infections due to non-availability of information.
-
Goal to End AIDS Epidemic by 2030 'Ambitious but Realistic': UN Chief
The world can end the AIDS epidemic by 2030, the United Nations said today, highlighting global success in rolling out life-saving drugs over the last 15 years.
-
MERS Cases Keep Coming From Samsung Hospital
Another doctor at a major hospital that has been the epicentre of MERS outbreak in Seoul has contracted the deadly virus, the government said Saturday.
-
Thailand Hospital Discharges Only MERS Case After Found Virus-Free
A 75-year-old Omani man who became Thailand's first case of Middle East Respiratory Syndrome (MERS) was discharged from hospital Friday after being declared free of the deadly virus, officials said.
-
Limp Corrected After 52 Years, Woman Walks Straight
Having fallen off her bed at the age of six months, a woman walked straight for the first time at the age of 52 following a total hip replacement (THR).
-
MERS Death Toll Rises to 31 in South Korea Outbreak, 1 New Case
Two more patients with Middle East Respiratory Syndrome (MERS) virus have died, South Korea's health ministry said on Friday bringing the total fatality to 31.
